The primary aims of antiretroviral therapy (ART) for HIV infection are to reduce morbidity and to prolong life by reducing viral load (VL) and increasing the CD4+ T-cell count with minimal toxicity/adverse event (AE). This evidence concerns the gene CD4 and HIV infectious disease.